WEBINAR | Pressure rising: Clinical controversies and updates in hypertension

Hypertension is responsible for the largest burden of cardiovascular disease (CVD) in Australia.¹ Even with gradual improvements in awareness and management, a significant proportion of hypertensive adults still fail to achieve recommended blood pressure (BP) targets.²  

Hosted live on World Heart Day 2021, this clinical webinar explores the latest evidence and controversies in BP management. Chaired by Prof. Garry Jennings, the expert discussion unpacks the latest clinical controversies in BP management including targets, resistant hypertension, and new digital technology for BP monitoring.

Duration: 1 hour
Year recorded: 2021

Topics covered:

• Controversies in BP targets and implications for practice post SPRINT trial
• Latest advice for the diagnosis and management of resistant hypertension
• Latest advice on out-of-office blood pressure monitoring
• Digital health tools on the horizon for CVD prevention and monitoring
• Applying new evidence to clinical practice to promote structured CVD prevention strategies

Further reading and resources:

• For your patients: tips for measuring BP at home and BP diary
• How to check if your BP device has been validated
• Guidelines for the diagnosis and management of hypertension 2016
• Absolute CVD Risk Guidelines 2012

Expert panelists 

	Prof. Rhian Touyz (international speaker) Executive Director and Chief Scientific Officer at the Research Institute of McGill University Health Centre, Montreal, Canada
	Prof. Markus Schlaich Dobney Chair in Clinical Research at The University of Western Australia and President of High Blood Pressure Research Council of Australia
	Prof. James Sharman Deputy Director and Head of the Blood Pressure Research Group at the Menzies Institute for Medical Research, University of Tasmania
	Prof. Nick Zwar GP and Executive Dean of the Faculty of Health Sciences and Medicine at Bond University

This event was hosted in partnership with the World Heart Federation and the High Blood Pressure Research Council of Australia. 


The activity was funded by the Commonwealth Department of Health, as part of the Public Health and Chronic Disease program.